Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry.
Couderc M, Gottenberg JE, Mariette X, Hachulla E, Sibilia J, Fain O, Hot A, Dougados M, Euller-Ziegler L, Bourgeois P, Larroche C, Tournadre A, Amoura Z, Mazières B, Arlet P, De Bandt M, Schaeverbeke T, Soubrier M.
Couderc M, et al.
Rheumatology (Oxford). 2011 Dec;50(12):2283-9. doi: 10.1093/rheumatology/ker305. Epub 2011 Oct 22.
Rheumatology (Oxford). 2011.
PMID: 22019807